Consider three AI developments that caught our eye at HealthExec this week. 

The purchase price could end up being closer to $200 million if certain commercial milestones are met.

Ziad Ali, MD, said the new device has completely changed the way he and his colleagues treat patients with calcified coronary artery disease.